25 Pharmaceutical industry, investigators and institutions: partners or tools? Practical issues in clinical cancer drug development. Erosion of the principal investigator in a climate of industry dominance
E.K. RowinskyVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80033-8
File:
PDF, 272 KB
english, 2004